midazolam has been researched along with Central Hypothyroidism in 2 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mustafa, FA | 1 |
| Bolon, M | 1 |
| Bastien, O | 1 |
| Flamens, C | 1 |
| Boulieu, R | 1 |
2 other studies available for midazolam and Central Hypothyroidism
| Article | Year |
|---|---|
Intravenous Midazolam as a Diagnostic Test for Catatonia.
Topics: Catatonia; Delayed Diagnosis; Electroconvulsive Therapy; Female; GABA Modulators; Hashimoto Disease; | 2017 |
Prolonged sedation due to an accumulation of midazolam in an intensive care patient with hypothyroidism.
Topics: Aged; Female; Humans; Hypnotics and Sedatives; Hypothyroidism; Midazolam | 2000 |